Article info
PDFResearch Article
Genetically determined obesity in Prader-Willi syndrome: the ethics and legality of treatment.
Citation
Genetically determined obesity in Prader-Willi syndrome: the ethics and legality of treatment.
Publication history
- First published June 1, 1999.
Online issue publication
June 01, 1999
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Other content recommended for you
- What is the value of growth hormone therapy in Prader Willi syndrome
- Gut microbiota of obese subjects with Prader - Willi syndrome is linked to metabolic health
- Growth hormone therapy in the Prader - Willi syndrome
- Hypoventilation disproportionate to OSAS severity in children with Prader - Willi syndrome
- Population prevalence and estimated birth incidence and mortality rate for people with Prader - Willi syndrome in one UK Health Region
- Enhanced activation of reward mediating prefrontal regions in response to food stimuli in Prader – Willi syndrome
- Multicentre study of maternal and neonatal outcomes in individuals with Prader - Willi syndrome
- Microarray analysis of gene / transcript expression in Prader - Willi syndrome: deletion versus UPD
- Prader - Willi syndrome: who can have growth hormone
- Death in adults with Prader - Willi syndrome may be correlated with maternal uniparental disomy